BGI Group presents a range of life science technologies, research capabilities, and application-oriented solutions at the 4th China International Supply Chain Expo, held in Beijing from June 22 to 26. The showcased portfolio spans health management, precision medicine, agriculture, consumer health, pet care, and laboratory innovation.

The China International Supply Chain Expo is a national-level exhibition focused on supply chains, bringing together organizations across upstream, midstream and downstream sectors, as well as enterprises, research institutions and international partners. BGI Group has participated in the expo for four consecutive years, using the platform to share developments in life science infrastructure, multi-omics technologies, applied research, and public-oriented health solutions.

BGI Group’s booth at the 4th China International Supply Chain Expo.

During the expo, BGI Group will present a series of new products and technologies, including tools for precision health assessment, personalized gut health management, skincare and anti-aging products, agricultural products, pet life-cycle health services, and advanced mass spectrometry detection technologies.

On June 24, BGI Group CEO Yin Ye will attend a health-focused thematic event and deliver a keynote speech.

AI and Omics-Based Tools for Preventive Health Management

BGI Group is highlighting new applications that integrate artificial intelligence, multi-omics technologies and health data analytics to support more proactive and personalized health management.

One of the featured products is an AI-enabled health assessment terminal, which is designed for low-contact, accessible health screening. Occupying approximately two square meters, the terminal uses multimodal intelligent cameras and simplified human-machine interaction to complete assessments across five dimensions - facial health indicators, vision, hearing, cognitive function and physical constitution - within 10 minutes. The system generates a digital report designed to translate complex health data into more understandable information for users. Potential deployment scenarios include business districts, hospitals and community settings.

The terminal is built under BGI’s 133111i health management framework, which uses whole-genome sequencing as a high-resolution personal baseline and integrates multi-omics data from blood, urine and stool samples, as well as imaging, physiological and brain health data. These inputs are used to generate quantitative indicators, including disease risk and aging assessment indexes, supporting more comprehensive personal health evaluation and disease risk prevention.

BGI Group is also introducing a new smart device focused on sleep health. Based on non-invasive brain-computer interface technology, the device applies personalized closed-loop transcranial electrical stimulation to support tailored sleep regulation interventions in a scientific and gentle manner.

For smart healthcare settings, BGI Genomics, a subsidiary of BGI Group, is presenting a new series of intelligent terminals powered by its self-developed GeneT large model, designed to support digitalization and intelligent upgrading in hospital-based clinical workflows. BGI Genomics is also presenting a methylation-based biological age assessment technology, which uses BGI’s targeted methylation high-throughput sequencing technology to assess individual biological aging status and provide genetic-level insights for precision health management.

In addition, BGI Genomics continues to present its precision medicine testing and service systems across key healthcare areas including reproductive health, cancer prevention and control, chronic disease management, and infectious disease prevention and control.

Applied Life Science Solutions for Everyday Health and Wellbeing

BGI Group is also showcasing a portfolio of consumer-facing and public-oriented innovations that apply life science research to everyday health and lifestyle scenarios.

In gut health, BGI is presenting probiotic products developed based on human gut microbiome research and its repository of human commensal bacteria. Alongside standardized products for broader populations, BGI is introducing a personalized gut health management service centered on at-home gut microbiome testing. The service decodes an individual’s gut microbiome profile, generates a dedicated report, and supports the development of personalized probiotic and prebiotic formulations, along with tailored care plans.

Visitors experience BGI Group’s skincare products.

In the skincare sector, BGI offers a one-stop skincare solution developed through 16 years of research. Spanning basic moisturization to advanced anti-aging care, it applies scientific skincare principles to help improve skin firmness and support a youthful-looking complexion.

Omics-Enabled Agriculture, Traceability and Sustainable Food Applications

BGI Group is showcasing applications of omics breeding and microecological technologies in modern agriculture, with an emphasis on improving productivity, supporting ecological sustainability, and strengthening quality control.

BGI’s agricultural technology portfolio includes perennial rice and perennial corn forage, which are designed to be planted once and harvested over multiple years, supporting both ecological protection and economic value creation. The company is also introducing a new three-in-one plant probiotic fertilizer, which applies microecological technology to modern agriculture and household gardening.

The exhibition also features traceable specialty agricultural and consumer products. These products use genetic traceability and ecological farming technologies to support quality management across the food supply chain.

During the exhibition, BGI Group launched two flavors of K-Cup coffee products, along with a compatible coffee machine. The machine can be connected to BGI’s self-developed coffee metabolism genetic testing device, which detects caffeine sensitivity and genetic metabolism indicators in 20 minutes. Its exclusive four-in-one adapter supports various brewing needs, enabling gene-based personalized coffee experiences.

Pet Health and Life-Cycle Care

BGI Group is also extending life science applications into pet health and care. Drawing on 26 years of technological experience in high-throughput sequencing, BGI has developed an integrated service chain covering pet breeding traceability, genetic and pathogen testing, and customized health services.

Visitors learn about BGI Group’s pet health products.

At the expo, the company is presenting science-based pet care solutions including pet genetic testing, pet gut health management, and customized life memorial diamonds. These offerings are designed to support breeders and pet owners with one-stop, life-cycle precision services, promote more informed pet care, and contribute to a more accessible and sustainable pet health ecosystem.

Laboratory Technologies and Research Infrastructure

In addition to application-oriented solutions, BGI Group is exhibiting technologies and equipment related to genome sequencing, spatial omics, synthetic biology, and laboratory automation and intelligence. These tools reflect BGI’s broader focus on building research infrastructure that can support scientific discovery, clinical translation and industrial collaboration.

Stable and collaborative supply chains are important to the development of life sciences and to the global economy. Through its participation in the 4th China International Supply Chain Expo, BGI Group aims to present how core life science technologies can be connected with research, healthcare, agriculture, consumer health and industrial partners.

BGI Group will continue to focus on the development of foundational technologies, research translation and collaborative innovation. Guided by its mission “Omics for All”, BGI Group seeks to work with partners across the global life science ecosystem to support more resilient, open and innovation-driven supply chains.